These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 14559427)

  • 1. A leukotriene receptor antagonist modulates iNOS in the lung and in a leukotriene-free cell model.
    Offer S; Shoseyov D; Bibi H; Eliraz A; Madar Z
    Nitric Oxide; 2003 Aug; 9(1):10-7. PubMed ID: 14559427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Montelukast, a leukotriene receptor antagonist, inhibits the late airway response to antigen, airway eosinophilia, and IL-5-expressing cells in Brown Norway rats.
    Ihaku D; Cameron L; Suzuki M; Molet S; Martin J; Hamid Q
    J Allergy Clin Immunol; 1999 Dec; 104(6):1147-54. PubMed ID: 10588994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.
    Murai A; Abe M; Hayashi Y; Sakata N; Katsuragi T; Tanaka K
    J Pharmacol Exp Ther; 2005 Feb; 312(2):432-40. PubMed ID: 15470084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of montelukast pretreatment on inducible nitric oxide synthase mRNA expression in the lungs of antigen-challenged allergic mice.
    Sade K; Schwartz I; Schwartz D; Wolman Y; Chernichovski T; Fireman E; Iaina A; Kivity S
    Clin Exp Allergy; 2003 Dec; 33(12):1741-6. PubMed ID: 14656364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Montelukast exerts no acute direct effect on NO synthases.
    Hamacher J; Eichert K; Braun C; Grebe T; Strub A; Lucas R; Eltze M; Wendel A
    Pulm Pharmacol Ther; 2007; 20(5):525-33. PubMed ID: 16815057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a cysteinyl leukotriene receptor antagonist on experimental emphysema and asthma combined with emphysema.
    Ikeda G; Miyahara N; Koga H; Fuchimoto Y; Waseda K; Kurimoto E; Taniguchi A; Tanimoto Y; Kataoka M; Tanimoto M; Kanehiro A
    Am J Respir Cell Mol Biol; 2014 Jan; 50(1):18-29. PubMed ID: 23937413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model.
    Henderson WR; Tang LO; Chu SJ; Tsao SM; Chiang GK; Jones F; Jonas M; Pae C; Wang H; Chi EY
    Am J Respir Crit Care Med; 2002 Jan; 165(1):108-16. PubMed ID: 11779739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cysteinyl leukotriene receptor antagonist montelukast ameliorates acute lung injury following haemorrhagic shock in rats.
    Al-Amran FG; Hadi NR; Hashim AM
    Eur J Cardiothorac Surg; 2013 Feb; 43(2):421-7. PubMed ID: 22851661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukotrienes produced in allergic lung inflammation activate alveolar macrophages.
    Silva RC; Landgraf MA; Hiyane MI; Pacheco-Silva A; Câmara NO; Landgraf RG
    Cell Physiol Biochem; 2010; 26(3):319-26. PubMed ID: 20798516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-inflammatory effect of montelukast, a cysteinyl leukotriene receptor-1 antagonist, against estradiol-induced nonbacterial inflammation in the rat prostate.
    Said MM; Bosland MC
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Feb; 390(2):197-205. PubMed ID: 27909742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant activity of histamine and cysteinyl leukotrienes on porcine nasal mucosal vessels and nasal inflammation in the rat.
    Lieber G; Jimenez J; Hunter JC; McLeod RL; Jia Y
    Pharmacology; 2010; 85(5):311-8. PubMed ID: 20453555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
    Shimbori C; Shiota N; Okunishi H
    Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukotriene receptor antagonist attenuated airway inflammation and hyperresponsiveness in a double-stranded RNA-induced asthma exacerbation model.
    Ujino M; Sugimoto N; Koizumi Y; Ro S; Kojima Y; Asae KH; Yamashita N; Ohta K; Nagase H
    Allergol Int; 2017 Sep; 66S():S21-S26. PubMed ID: 28647381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
    Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
    Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
    Muraki M; Imbe S; Sato R; Ikeda Y; Yamagata S; Iwanaga T; Tohda Y
    Int Immunopharmacol; 2009 Oct; 9(11):1337-41. PubMed ID: 19706339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cysteinyl leukotriene receptor antagonist epigenetically modulates cytokine expression and maturation of human myeloid dendritic cells.
    Kuo CH; Yang SN; Kuo HF; Lee MS; Huang MY; Huang SK; Lin YC; Hsieh CC; Hung CH
    Pulm Pharmacol Ther; 2016 Aug; 39():28-37. PubMed ID: 27312202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Montelukast modulates lung CysLT(1) receptor expression and eosinophilic inflammation in asthmatic mice.
    Zhang YJ; Zhang L; Wang SB; Shen HH; Wei EQ
    Acta Pharmacol Sin; 2004 Oct; 25(10):1341-6. PubMed ID: 15456537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory effects of high-dose montelukast in an animal model of acute asthma.
    Wu AY; Chik SC; Chan AW; Li Z; Tsang KW; Li W
    Clin Exp Allergy; 2003 Mar; 33(3):359-66. PubMed ID: 12614451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effects of the cys-leukotriene-1 receptor antagonist, montelukast, on experimental colitis in rats.
    Holma R; Salmenperä P; Riutta A; Virtanen I; Korpela R; Vapaatalo H
    Eur J Pharmacol; 2001 Oct; 429(1-3):309-18. PubMed ID: 11698051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardioprotective effect and influence on NOS expression of Montelukast sodium in rats].
    Chen S; Jin G; Shan J; Zhang M; Men Q; Xu L
    Yao Xue Xue Bao; 2003 Nov; 38(11):821-5. PubMed ID: 14991993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.